With a sweep of the pen, President Donald Trump has ended a Biden administration effort to decrease the price of pharmaceuticals for individuals on Medicare and Medicaid.
A type of now-cancelled insurance policies directed Medicare to research methods to slash drug prices, together with the potential of a $2 month-to-month out-of-pocket cap on some generic drugs.
A key provision in former President Joe Biden’s Inflation Discount Act, negotiating Medicare drug costs, stays untouched for now. Final week, Medicare unveiled an inventory of pharmaceuticals up for negotiations subsequent. They included Ozempic and Wegovy, the favored weight-loss and diabetes medicine.
He stated the president is aware of that well being care prices in america are far greater than in different a part of the world and that the federal government could have to intervene.
Larry Levitt, an govt vice chairman at KFF, a well being coverage assume tank, provided an analogous evaluation.
By cancelling Biden’s order to research new methods to decrease out-of-pocket spending on prescription drugs, Levitt stated Trump could also be signaling that he’s much less critical about addressing well being care prices.
“Trump is kind of wiping the slate clean,” Levitt concluded. “If you contrast Day 1 of this Trump administration with the last one, it is a different approach to health care.”
Extra info:
There’s extra about seniors’ drug protection at Medicare.gov.
© 2025 HealthDay. All rights reserved.
Quotation:
Trump ends push to slash prescription drug prices (2025, January 22)
retrieved 23 January 2025
from https://medicalxpress.com/information/2025-01-trump-slash-prescription-drug.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.
